Abalones are edible shellfish and a valuable food source in Asian countries. Although substances from abalone have bioactivities, such as anti-oxidation and anti-inflammation, anti-metastatic effects of abalone have not been fully revealed. Gastric cancer is a common malignant cancer, but prognosis is poor because of its high metastatic characteristics. In this study, a novel peptide (A2) from abalone (Haliotis discus hannai) was applied to investigate its antimetastatic effects in MKN-28 gastric cancer cells. Enhanced activities of glycogen-synthase kinase 3β(GSK-3β) by A2 treatment contributed to modulation of β-catenin; hence, β-catenin signaling was downregulated, and translocation of β-catenin to the nucleus was repressed. Moreover, cellular protrusions including lamellipodia and filopodia were disrupted through downregulation of Rac1 and Cdc42 in response to A2 in MKN-28 cells. It is suggested that A2 inhibits cell migration through controlling levels of β-catenin, GSK-3β, and also induced disorganization of lamellipodia and filopodia. Therefore, A2 possesses therapeutic properties to treat gastric cancer.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.
Vol. 35 • No. 3